HOUSTON–( ORGANIZATION CORD)– EndoQuest Robotics, Inc., an introducing leader in endoluminal robot medical modern technology, today introduced that the united state Fda (FDA) has actually authorized initiation of the following and last of its crucial multicenter test, the standard Test (Possible Analysis of a Robotic Assisted Gadget in Gastrointestinal Medication). The standard Test is an Investigational Gadget Exception (IDE) research study assessing EndoQuest’s Endoluminal Surgical (ELS) System fo
发布者：Dr.Durant，转转请注明出处：https://robotalks.cn/endoquest-receives-fda-approval-to-initiate-final-stage-of-paradigm-trial/
